Literature DB >> 35511299

Regulatory network identified by pulmonary transcriptome and proteome profiling reveals extensive change of tumor-related genes in microRNA-21 knockout mice.

Ge Luan1,2, Ming Wang1,2, Jing Yuan1,2, Xiangting Bu1,2, Jing Song1,2, Chengshuo Wang3,4, Luo Zhang5,6,7,8.   

Abstract

PURPOSE: MicroRNA-21 (miR-21) is a well-known oncomiR and plays key roles in regulating various biological processes related to pulmonary diseases, especially lung carcinoma. The regulatory roles and downstream targets of miR-21 remain far from well understood. We aimed to identify miR-21-gene regulatory network in lung tissue.
METHODS: Transcriptome and proteome analyses were performed on lung tissues from miR-21 knockout (KO) mice and their wildtype (WT) littermates. Differentially expressed genes (DEGs) and proteins (DEPs) between miR-21KO and WT were analyzed, and correlation analysis was performed between transcriptional and translational level. DEPs were used for prediction of miR-21 target genes and construction of co-expression network.
RESULTS: Comparing with WT mice, 820 DEGs and 623 DEPs were identified in lung tissues of miR-21KO mice. Upregulated DEGs and DEPs were both significantly enriched in pathways of metabolism of xenobiotics by cytochrome P450, drug metabolism, and chemical carcinogenesis. Of the 31 molecules commonly identified in DEGs and DEPs, 9 upregulated genes were tumor suppressor genes while 8 downregulated genes were oncogenes, and 12 genes showed closely positive correlation between mRNA and protein expression. Real-time PCR validation results were consistent with the omics data. Among the upregulated DEPs in miR-21KO mice, 21 genes were predicted as miR-21 targets. The miR-21 regulatory network was constructed by target genes and their highly co-expressed proteins, which identified the miR-21 target Itih4 as a hub gene.
CONCLUSION: MiR-21-gene regulatory network was constructed in mouse lung tissue. MiR-21KO resulted in extensive upregulation of tumor suppressor genes and downregulation of oncogenes.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Cancer; MicroRNA-21; Proteome; Regulatory network; Transcriptome

Mesh:

Substances:

Year:  2022        PMID: 35511299     DOI: 10.1007/s00432-022-03967-6

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.322


  39 in total

Review 1.  MicroRNAs: genomics, biogenesis, mechanism, and function.

Authors:  David P Bartel
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

2.  MicroRNA-21 deficiency attenuated atherogenesis and decreased macrophage infiltration by targeting Dusp-8.

Authors:  Lin Gao; Huasu Zeng; Tiantian Zhang; Chengyu Mao; Yue Wang; Zhihua Han; Kan Chen; Junfeng Zhang; Yuqi Fan; Jun Gu; Changqian Wang
Journal:  Atherosclerosis       Date:  2019-10-11       Impact factor: 5.162

3.  Characterization of liver injury, oval cell proliferation and cholangiocarcinogenesis in glutathione S-transferase A3 knockout mice.

Authors:  Dana R Crawford; Zoran Ilic; Ian Guest; Ginger L Milne; John D Hayes; Stewart Sell
Journal:  Carcinogenesis       Date:  2017-07-01       Impact factor: 4.944

4.  Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21.

Authors:  Mark E Hatley; David M Patrick; Matthew R Garcia; James A Richardson; Rhonda Bassel-Duby; Eva van Rooij; Eric N Olson
Journal:  Cancer Cell       Date:  2010-09-14       Impact factor: 31.743

Review 5.  Overview upon miR-21 in lung cancer: focus on NSCLC.

Authors:  Cecilia Bica-Pop; Roxana Cojocneanu-Petric; Lorand Magdo; Lajos Raduly; Diana Gulei; Ioana Berindan-Neagoe
Journal:  Cell Mol Life Sci       Date:  2018-07-20       Impact factor: 9.261

6.  Disruption of microRNA-21 by TALEN leads to diminished cell transformation and increased expression of cell-environment interaction genes.

Authors:  Buyuan Chen; Xinji Chen; Xiwei Wu; Xiaoling Wang; Yingjia Wang; Ting-Yu Lin; Jessica Kurata; Jun Wu; Steven Vonderfecht; Guihua Sun; He Huang; Jiing-Kuan Yee; Jianda Hu; Ren-Jang Lin
Journal:  Cancer Lett       Date:  2014-10-07       Impact factor: 8.679

Review 7.  Cytochrome P450: Polymorphisms and Roles in Cancer, Diabetes and Atherosclerosis

Authors:  Imadeldin Elfaki; Rashid Mir; Fahad M Almutairi; Faisel M Abu Duhier
Journal:  Asian Pac J Cancer Prev       Date:  2018-08-24

8.  Very long-chain fatty acids are accumulated in triacylglycerol and nonesterified forms in colorectal cancer tissues.

Authors:  Kotaro Hama; Yuko Fujiwara; Tamuro Hayama; Tsuyoshi Ozawa; Keijiro Nozawa; Keiji Matsuda; Yojiro Hashiguchi; Kazuaki Yokoyama
Journal:  Sci Rep       Date:  2021-03-17       Impact factor: 4.379

9.  Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool.

Authors:  Edward Y Chen; Christopher M Tan; Yan Kou; Qiaonan Duan; Zichen Wang; Gabriela Vaz Meirelles; Neil R Clark; Avi Ma'ayan
Journal:  BMC Bioinformatics       Date:  2013-04-15       Impact factor: 3.169

10.  Relationship between inter-α-trypsin inhibitor heavy chain 4 and ovarian cancer.

Authors:  Min Huang; Wei Zhang; Bingbing Zhao; Li Li
Journal:  Chin J Cancer Res       Date:  2019-12       Impact factor: 5.087

View more
  1 in total

Review 1.  OncomiRs as noncoding RNAs having functions in cancer: Their role in immune suppression and clinical implications.

Authors:  Khalid Otmani; Redouane Rouas; Philippe Lewalle
Journal:  Front Immunol       Date:  2022-09-16       Impact factor: 8.786

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.